Nemaura Medical Statistics
Share Statistics
Nemaura Medical has 40.35M shares outstanding. The number of shares has increased by 39.63% in one year.
| Shares Outstanding | 40.35M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 10.63M |
| Failed to Deliver (FTD) Shares | 6 |
| FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 52.57K, so 0.13% of the outstanding shares have been sold short.
| Short Interest | 52.57K |
| Short % of Shares Out | 0.13% |
| Short % of Float | 0.49% |
| Short Ratio (days to cover) | 0.3 |
Valuation Ratios
The PE ratio is -1.57 and the forward PE ratio is null.
| PE Ratio | -1.57 |
| Forward PE | null |
| PS Ratio | 289 |
| Forward PS | null |
| PB Ratio | -1.88 |
| P/FCF Ratio | -2.48 |
| PEG Ratio | n/a |
Enterprise Valuation
Nemaura Medical Inc. has an Enterprise Value (EV) of 32.19M.
| EV / Earnings | -2.28 |
| EV / Sales | 417.83 |
| EV / EBITDA | -4.42 |
| EV / EBIT | -3.35 |
| EV / FCF | -3.58 |
Financial Position
The company has a current ratio of 0.61, with a Debt / Equity ratio of -1.7.
| Current Ratio | 0.61 |
| Quick Ratio | 0.53 |
| Debt / Equity | -1.7 |
| Total Debt / Capitalization | 243.8 |
| Cash Flow / Debt | -0.42 |
| Interest Coverage | -1.5 |
Financial Efficiency
Return on equity (ROE) is 1.2% and return on capital (ROIC) is -116.79%.
| Return on Equity (ROE) | 1.2% |
| Return on Assets (ROA) | -0.97% |
| Return on Capital (ROIC) | -116.79% |
| Revenue Per Employee | 2.14K |
| Profits Per Employee | -392.88K |
| Employee Count | 36 |
| Asset Turnover | 0.01 |
| Inventory Turnover | 0.89 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is 0.08, so Nemaura Medical 's price volatility has been higher than the market average.
| Beta | 0.08 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 37.62 |
| Average Volume (20 Days) | 7.69K |
Income Statement
In the last 12 months, Nemaura Medical had revenue of 77.04K and earned -14.14M in profits. Earnings per share was -0.57.
| Revenue | 77.04K |
| Gross Profit | -1.48M |
| Operating Income | -9.60M |
| Net Income | -14.14M |
| EBITDA | -7.29M |
| EBIT | -9.60M |
| Earnings Per Share (EPS) | -0.57 |
Balance Sheet
The company has 10.11M in cash and 20.03M in debt, giving a net cash position of -9.93M.
| Cash & Cash Equivalents | 10.11M |
| Total Debt | 20.03M |
| Net Cash | -9.93M |
| Retained Earnings | -51.88M |
| Total Assets | 5.17M |
| Working Capital | -18.62M |
Cash Flow
In the last 12 months, operating cash flow was -8.45M and capital expenditures -539.22K, giving a free cash flow of -8.99M.
| Operating Cash Flow | -8.45M |
| Capital Expenditures | -539.22K |
| Free Cash Flow | -8.99M |
| FCF Per Share | -0.36 |
Margins
Gross margin is -1.92K%, with operating and profit margins of -12.45K% and -18.36K%.
| Gross Margin | -1.92K% |
| Operating Margin | -12.45K% |
| Pretax Margin | -18.36K% |
| Profit Margin | -18.36K% |
| EBITDA Margin | -9.46K% |
| EBIT Margin | -12.45K% |
| FCF Margin | -11.67K% |
Dividends & Yields
NMRD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | -222825.23% |
Analyst Forecast
Currently there are no analyst rating for NMRD.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 5, 2019. It was a backward split with a ratio of 1:10.
| Last Split Date | Dec 5, 2019 |
| Split Type | backward |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | -25.18 |
| Piotroski F-Score | 1 |